Piperine’s targeting of particular proteins that are overexpressed in colon cancer cells—particularly AURKA (Aurora kinase A) and CDK1, which are important regulators of cell cycle progression—is what causes this synergy. The gene discussed is AURKA; the disease is colonic neoplasm.